SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-012996
Filing Date
2024-02-08
Accepted
2024-02-08 21:08:42
Documents
1
Period of Report
2024-02-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5697
  Complete submission text file 0000950170-24-012996.txt   7273
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400 CAMBRIDGE MA 02139
Business Address
Beckman Daniella (Reporting) CIK: 0001513422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39485 | Film No.: 24610902

Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)